Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.
Chronic nonbacterial prostatitis/chronic pelvic pain syndrome is a common entity for which a standardized management has not been established. Patients often have a significant symptom complex and impact on quality of life, but very little is known about the efficacy of second- and third-line treatments, such as the use of herbal supplements. Many treatments studied in recent literature include antibiotics, alpha-blockade, anti-inflammatory agents, and cognitive behavioral interventions such as biofeedback and psychotherapy.
Yang
Jennifer
J
Department of Urology, Weill Medical College of Cornell University, New York, NY 10021, USA.
Te
Alexis E
AE
D058891:5-alpha Reductase Inhibitors; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017699:Pelvic Pain / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011472:Prostatitis / Q000188:drug therapy*; D028024:Serenoa; D013577:Syndrome; D016896:Treatment Outcome
D058891:5-alpha Reductase Inhibitors; D000726:Androgen Antagonists; D004791:Enzyme Inhibitors; D010936:Plant Extracts; D018120:Finasteride; C040972:saw palmetto extract